Giant cell fibroblastoma
Citation, DOI, disclosures and article data
Giant cell fibroblastomas are locally aggressive mesenchymal neoplasms closely related to dermatofibrosarcoma protuberans.
Giant cell fibroblastomas are rare. They are usually but not exclusively found in children within the first decade of life, adult cases are rare. Boys are more commonly affected 1-3.
Giant cell fibroblastomas are closely related to dermatofibrosarcoma protuberans 1-3.
The diagnosis of giant cell fibroblastomas is established by location, histological and molecular pathologic criteria 2.
Diagnostic criteria according to the WHO classification of tumors: soft tissue and bone (5th edition) 2:
- infiltrative borders within the skin and subcutis
- hypocellular lesion with a collagenous or myxoid background
- composition of spindle cells stellate tumor cells and scattered multinucleated giant cells
- irregular branching pseudovascular spaces often lined by multinucleated giant cells
The following diagnostic criterion is desirable:
- COL1A1-1-PDGFB fusion
Giant cell fibroblastomas usually present as plaque-like, painless, slow-growing cutaneous lesions 1,2.
Pathologically giant cell fibroblastomas are characterized by multinucleated giant cells, pseudovascular spaces and on a molecular basis by a COL1A1-1-PDGFB fusion 2. They usually involve the subcutaneous tissue and the dermis and rarely infiltrate the skeletal muscle superficially 1-3.
The etiology of giant cell fibroblastomas is currently unknown 1.
Tumors are most commonly found in the trunk, groin or axillae and far less often in the extremities or head and neck region 1,2.
Macroscopically tumors are ill-defined infiltrative lesions with a grey to yellowish color and mucoid cut surface. Size can be quite variable ranging from <1 cm to 8 cm with a median size of 3-4 cm 1,2.
Histologically giant cell fibroblastomas are characterized by the following 1-4:
- mainly subcutaneous location with infiltration of the skin and very rarely the skeletal muscle
- honeycomb or parallel growth patterns
- sparing of subcutaneous adnexal structures
- variable cellularity but commonly hypocellular areas in a myxoid to collagenous stroma
- tumor composition of spindle cells, stellate cells and multinucleated giant cells
- wreath-like arrangement of nuclei
- rare mitoses, absent tumor necrosis
COL1A1-1-PDGFB fusions are characteristic 1.
At the time of writing, there are only very few reports of the radiological features of this entity 4,5.
On ultrasound a tumor described in one case has been characterized as hypoechoic with well-defined margins and internal irregular septum-like echogenic structures 4.
On MRI one case showed different signal intensity in the centrum and the periphery on fluid-sensitive T2 weighted images with a bright edge and lower signal in the center 4. Another report described multiloculated vessels and septations within the mass 5.
(compared to skeletal muscle)
- T1: iso to hypointense to skeletal muscle
- T2: slightly hyperintense to skeletal muscle
- T1 C+ (Gd): intense peripheral enhancement
The radiological report should include a description of the following:
- form, location and size
- infiltrative tumor margins
- relation to muscular fasciae and skeletal muscles
- relationship to local nerves and vessels
- local lymph nodes
Treatment and prognosis
Management consists of surgical excision, and local recurrences of up to 50% have been described. However, upon wide local excision recurrences are rare 2,3.
History and etymology
Gian cell fibroblastomas were first described by the American pathologist Barry M Shmookler and the Austrian-American pathologist Franz Michael Enzinger in 1982 1,3,6.
Conditions that can mimic the presentation and/or the appearance of giant cell fibroblastoma include the following:
- 1. Shmookler B, Enzinger F, Weiss S. Giant Cell Fibroblastoma. A Juvenile Form of Dermatofibrosarcoma Protuberans. Cancer. 1989;64(10):2154-61. doi:10.1002/1097-0142(19891115)64:10<2154::aid-cncr2820641030>3.0.co;2-n - Pubmed
- 2. Mentzel TDW, Pedeutour F. Giant cell fibroblastoma. In: WHO Classification of Tumours Editorial Board. Soft tissue and bone tumours. Lyon (France): International Agency for Research on Cancer; 2020. (WHO classification of tumours series, 5th ed.; vol. 3). https://publications.iarc.fr
- 3. Jha P, Moosavi C, Fanburg-Smith J. Giant Cell Fibroblastoma: An Update and Addition of 86 New Cases from the Armed Forces Institute of Pathology, in Honor of Dr. Franz M. Enzinger. Ann Diagn Pathol. 2007;11(2):81-8. doi:10.1016/j.anndiagpath.2006.12.010 - Pubmed
- 4. Min S, Park S, Seo J, Koh S, Lee K. Ultrasound and MRI Findings of Giant Cell Fibroblastoma in the Abdominal Wall: Radiologic-Pathologic Correlations. Taehan Yongsang Uihakhoe Chi. 2020;81(1):237-42. doi:10.3348/jksr.2020.81.1.237 - Pubmed
- 5. Sanchez JE. Giant Cell Fibroblastoma. The American Journal of Dermatopathology 2006; 28(3): 228.
- 6. Shmookler BM, Enzinger FM. Giant cell fibroblastoma: A peculiar childhood tumor (Abstr). Lab Invest 1982; 46:76.